The global antifungal treatment market is growing moderately and expected to grow at the same pace over the forecast period 2017-2013. Increasing number of patients with fungal diseases and growing prevalence of HIV are the key factors of the market growth. Additionally, rising geriatric population is one of the important drivers of the market growth.
The Global Antifungal Treatment Market is expected to grow at a CAGR of 4.61% during the forecast period and is estimated to reach USD 19,558.0 million by 2023.
Fungal infections such as athlete’s foot, ringworm infection, serious systemic infections, and others are spreading unexpectedly throughout the globe and some of remedies are to be had to deal with these diseases. Growing prevalence of immunological sickness and availability of an extensive range of merchandise have driven the growth of the global antifungal remedy market. Moreover, growing attention about side outcomes of traditional drugs and availability of new pills favor the boom of the market.
Taste the market data and market information presented through more than 80 market data tables and figures spread over 108 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “anti-fungal treatment market research report–Global forecast till 2023.”
Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/1628 .
Key Players in the Global Antifungal Treatment Market
Some of the key players in this market are
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S)
- Sanofi (France)
- Merck & Co., Inc. (U.S)
- Astellas (Japan)
- Bayer AG (Germany)
Regional Analysis of Global Antifungal Treatment Market
Considering the global scenario of the market, the Americas accounted for a significant market share in 2016, which was valued at USD 5,539.4 million as a result of increasing prevalence of immunological diseases and rising healthcare expenditure.
Europe is the second largest market and holds a noticeable share in the global antifungal treatment market. The European market is expected to grow significantly during the forecast period owing to availability of advanced treatment facilities, skilled medical professionals, and adoption of new therapies.
Increasing prevalence of HIV in Asia Pacific region is the key factor for the market growth. Rising awareness about the antifungal treatment and availability of new treatment methods drive the market in Asia Pacific region. In Asia Pacific, the market shows growth opportunities in China and India. China is expected to be the fastest growing market with the CAGR of 5.24% during the forecasted period.
Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/1628 .
The Middle East & Africa is expected to show the least growth in this market due to some major factors such as lack of awareness about the anti-fungal treatment, limited access and availability of treatment facilities, low income etc.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312